| |
| |
|
| Insider
Information: |
Murphy Andrew J |
| Relationship: |
EVP Research |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
48,306 |
|
|
Indirect Shares
|
4,310 |
|
|
| Direct
Value |
$42,663,859 |
|
|
|
Indirect Value
|
$3,806,592 |
|
|
| Total
Shares |
52,616 |
|
|
| Total
Value |
$46,470,451 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Research |
2024-03-14 |
48,306 |
2024-03-14 |
4,310 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2024-03-14 |
4 |
AS |
$951.92 |
$5,531,290 |
D/D |
(5,783) |
48,306 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2024-03-13 |
4 |
D |
$971.82 |
$13,816,365 |
D/D |
(14,217) |
54,089 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2024-03-13 |
4 |
OE |
$399.66 |
$7,993,200 |
D/D |
20,000 |
68,306 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-12-12 |
4 |
D |
$856.71 |
$6,559,828 |
D/D |
(7,657) |
48,306 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-12-11 |
4 |
D |
$844.09 |
$4,873,776 |
D/D |
(5,774) |
55,963 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-12-08 |
4 |
D |
$843.79 |
$745,067 |
D/D |
(883) |
58,538 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,199 |
61,737 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-12-05 |
4 |
AS |
$810.38 |
$5,342,787 |
D/D |
(6,536) |
59,421 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-12-04 |
4 |
D |
$813.58 |
$10,954,041 |
D/D |
(13,464) |
65,957 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-12-04 |
4 |
OE |
$270.43 |
$5,408,600 |
D/D |
20,000 |
79,421 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-11-14 |
4 |
AS |
$794.57 |
$5,188,213 |
D/D |
(6,492) |
59,421 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-11-13 |
4 |
D |
$795.69 |
$10,748,181 |
D/D |
(13,508) |
65,913 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-11-13 |
4 |
OE |
$270.43 |
$5,408,600 |
D/D |
20,000 |
79,421 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-05-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,326 |
59,421 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,129 |
60,747 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-12-09 |
4 |
D |
$753.28 |
$370,614 |
D/D |
(492) |
56,618 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-11-15 |
4 |
AS |
$718.60 |
$2,707,467 |
D/D |
(3,720) |
57,110 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-11-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,360 |
57,110 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-11-14 |
4 |
OE |
$179.13 |
$1,791,300 |
D/D |
10,000 |
67,110 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-11-14 |
4 |
D |
$746.00 |
$4,684,880 |
D/D |
(6,280) |
60,830 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-08-16 |
4 |
AS |
$639.85 |
$2,267,600 |
D/D |
(3,513) |
58,470 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-08-15 |
4 |
D |
$634.25 |
$4,114,380 |
D/D |
(6,487) |
61,983 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-08-15 |
4 |
OE |
$179.13 |
$1,791,300 |
D/D |
10,000 |
68,470 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-05-17 |
4 |
AS |
$655.40 |
$2,351,411 |
D/D |
(3,543) |
58,470 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-05-16 |
4 |
D |
$648.31 |
$4,186,138 |
D/D |
(6,457) |
62,013 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
